Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06868433Phase 1Recruiting
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
PrincipalinvestigatorStart date: 2025-05-08

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Siwen Hu-Lieskovan

SWOG Cancer Research Network

Related
2 trials

Shared therapeutic areas:

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

George Blumenschein, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Nabil F. Saba, MD

Emory University

Related
2 trials

Shared therapeutic areas:

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

Emory UniversityNational Cancer Institute (NCI)+1 more
Similarity Score7%

Athanassios (Ethan) Argiris

ECOG-ACRIN Cancer Research Group

Related
2 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Kathryn M. Van Abel, MD

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+1 more
Similarity Score5%

Eileen H Shinn

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IV Hypopharyngeal Carcinoma AJCC v8Stage IV Laryngeal Cancer AJCC v8Stage IV Nasopharyngeal Carcinoma AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Roxana S. Dronca, M.D.

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Similarity Score4%

Mojun Zhu, M.D.

Mayo Clinic in Rochester

Related
2 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Similarity Score4%

Hassan Arshad

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)National Institutes of Health (NIH)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06868433Phase 1PrincipalInvestigator

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Recruiting

All 1 trials loaded